- Home
- NBY vs BTA Comparison
NBY vs BTA Comparison
Compare NBY & BTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBY
- BTA
- Stock Information
- Founded
- NBY 2000
- BTA 2006
- Country
- NBY United States
- BTA United States
- Employees
- NBY N/A
- BTA N/A
- Industry
- NBY
- BTA Trusts Except Educational Religious and Charitable
- Sector
- NBY
- BTA Finance
- Exchange
- NBY Nasdaq
- BTA Nasdaq
- Market Cap
- NBY 15.7M
- BTA 119.9M
- IPO Year
- NBY 2007
- BTA N/A
- Fundamental
- Price
- NBY $2.19
- BTA $9.69
- Analyst Decision
- NBY Strong Buy
- BTA
- Analyst Count
- NBY 1
- BTA 0
- Target Price
- NBY $0.85
- BTA N/A
- AVG Volume (30 Days)
- NBY 21.5M
- BTA 21.9K
- Earning Date
- NBY 11-06-2025
- BTA 01-01-0001
- Dividend Yield
- NBY N/A
- BTA 5.22%
- EPS Growth
- NBY N/A
- BTA N/A
- EPS
- NBY 0.41
- BTA N/A
- Revenue
- NBY $9,781,000.00
- BTA N/A
- Revenue This Year
- NBY $23.91
- BTA N/A
- Revenue Next Year
- NBY $32.05
- BTA N/A
- P/E Ratio
- NBY $5.34
- BTA N/A
- Revenue Growth
- NBY 113.47
- BTA N/A
- 52 Week Low
- NBY $0.46
- BTA $8.59
- 52 Week High
- NBY $4.44
- BTA $10.62
- Technical
- Relative Strength Index (RSI)
- NBY 52.97
- BTA 78.47
- Support Level
- NBY $2.28
- BTA $8.90
- Resistance Level
- NBY $3.30
- BTA $9.79
- Average True Range (ATR)
- NBY 0.64
- BTA 0.10
- MACD
- NBY -0.03
- BTA 0.07
- Stochastic Oscillator
- NBY 24.65
- BTA 88.76
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.
About BTA BlackRock Long-Term Municipal Advantage Trust of Beneficial Interest
Blackrock Long-term Municipal AdtgTrust is a diversified investment fund with an investment objective to provide current income exempt from regular U.S. federal income tax. The Fund invests more of its total assets in municipal bonds, municipal securities, and derivative instruments.